Abstract
Goblet cell carcinoid (GCC) of the appendix is currently classified as a neuroendocrine tumor, together with typical carcinoid (TC) of the appendix. However, whether GCC is a variant of TC or a mucin-producing adenocarcinoma is still controversial. To get a better understanding, we investigated the clinicopathological features of 55 Chinese patients (26 GCCs and 29 TCs), and explored the histochemical properties and expression profiles of CK7, CK20, P63, CEA, CgA, NSE, CD56, and Ki67 in 37 out of these 55 patients (18 GCCs and 19 TCs). Our results showed GCC had a male predominance, older age involvement, significantly larger tumor size, and significantly more frequency of mesoappendix infiltration than TC. Alcian blue/PAS stains were positive in all the GCC cases, while negative in all the TC cases. CK7 and CK20 expressions were significantly more frequent in GCC (P = 0.03 and 0.00001, respectively). However, P63 expression was detected in none of the GCC cases but in 6 TC cases (P = 0.02). Although the expression of CgA was similar, strong expression (3+) was significantly more frequent in TC (P = 5.7 × 10−11). Also, NSE and CD56 expressions were significantly more frequent in TC (P = 0.02 and 1.26 × 10−4, respectively). CEA expression was significantly more frequent in GCC (P = 2.4 × 10−6). Finally, Ki67 index was low in GCC (4.7%), but significantly higher than TC (0.9%) (P = 5.4 × 10−6). Taken together, these distinct features support that GCC differs from TC, a classical neuroendocrine tumor, and harbors an immunophenotype of adenocarcinoma. Therefore, the term “low grade adenocarcinoma with neuroendocrine differentiation” might be more appropriate for GCC.
Similar content being viewed by others
Abbreviations
- GCC:
-
Goblet Cell Carcinoid
- TC:
-
Typical Carcinoid
- HPF:
-
High Power Field
References
Capella C, Solcia E, Sobin LH, Arnold R (2000) Endocrine tumors of the appendix. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive system. In: Hamilton SR, Aaltonen LA (ed) IARC Press, Lyon, pp 99–101
Pahlavan PS, Kanthan R (2005) Goblet cell carcinoid of the appendix. World J Surg Oncol 3:36
Kanthan R, Saxena A, Kanthan SC (2001) Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med 125(3):386–90
Park K, Blessing K, Kerr K, Chetty U, Gilmour H (1990) Goblet cell carcinoid of the appendix. Gut 31:322–324
Deans GT, Spence RA (1995) Neoplastic lesions of the appendix. Br J Surg 82:299–306
Butler TA, Houshiar A, Lin F, Wilson SE (1994) Goblet cell carcinoid of the appendix. Am J Surg 168:685–687
Alsaad KO, Serra S, Schmitt A, Perren A, Chetty R (2007) Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix. Endocr Pathol 18(1):16–22
van Eeden S, Offerhaus GJ, Hart AA et al (2007) Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 51(6):763–73
Ramnani DM, Wistuba II, Behrens C et al (1999) K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer 86(1):14–21
Stancu M, Wu TT, Wallace C et al (2003) Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol 16(12):1189–98
Subbuswamy SG, Gibbs NM, Ross CF, Morson BC (1974) Goblet cell carcinoid of the appendix. Cancer 34(2):338–44
Kende AI, Carr NJ, Sobin LH (2003) Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 42(2):137–40
Toumpanakis C, Standish RA, Baishnab E, Winslet MC, Caplin ME (2007) Goblet cell carcinoid tumors (adenocarcinoid) of the appendix. Dis Colon Rectum 50(3):315–22
Wang BY, Gil J, Kaufman D et al (2002) P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33(9):921–6
Owens SR, Greenson JK (2007) Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas. Am J Surg Pathol 31(2):285–90
Sokmensuer C, Gedikoglu G, Uzunalimoglu B (2001) Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study. Hepatogastroenterology 48(39):720–3
Li CC, Hirowaka M, Qian ZR, Xu B, Sano T (2002) Expression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation. Endocr Pathol 13(1):47–58
McCusker ME, Cote TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer 94(12):3307–12
Konishi T, Watanabe T, Muto T, Kotake K, Nagawa H (2006) Site distribution of gastrointestinal carcinoids differs between races. Gut 55(7):1051–2
Acknowledgement
We thank Kaixuan Yang, Ping Hua, Zhirong Yang, and Ling Wu for their providing the specimens.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiang, Y., Long, H., Wang, W. et al. Clinicopathological Features and Immunoexpression Profiles of Goblet Cell Carcinoid and Typical Carcinoid of the Appendix. Pathol. Oncol. Res. 17, 127–132 (2011). https://doi.org/10.1007/s12253-010-9291-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-010-9291-5